GSK: FDA, EMA Concluded No Evidence Of Causal Link Between Ranitidine Therapy, Cancer

 SAYS FDA AND EMA HAVE CONCLUDED THERE IS NO EVIDENCE OF A CAUSAL ASSOCIATION BETWEEN RANITIDINE THERAPY AND THE DEVELOPMENT OF CANCER

* PLAINTIFF LITIGATION INCONSISTENT WITH SCIENTIFIC CONSENSUS, GSK WILL VIGOROUSLY DEFEND ALL CLAIMS

https://www.marketscreener.com/quote/stock/GSK-PLC-9590199/news/GSK-Says-U-S-FDA-And-EMA-Have-Concluded-There-Is-No-Evidence-Of-A-Causal-Association-Between-Raniti-41285694/